VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors	Myosarcoma, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, myomatous neoplasm, neoplasm, rhabdomyosarcoma, sarcoma	Recruiting	Phase 1 / Phase 2	2026-06-02		NCT04796012

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Texas Southwestern Medical Center	295

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	United States	144
Boston Children's Hospital	Boston	United States	343
Children's Hospital of Philadelphia	Philadelphia	United States	434
Cincinnati Children's Hospital	Cincinnati	United States	66
Seattle Children's	Seattle	United States	21
Texas Children's Hospital	Houston	United States	187
The University of Texas Southwestern Medical Center	Dallas	United States	3